Xuanming Hong

Xuanming Hong

Auto-generated profile, based on publicly available information

Xuanming Hong

Department of Epidemiology and Biostatistics, School of Public Health Peking University Beijing China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Hypertension
Verified
Journal Article
Open access
PDF file
XHXuanming Hong
Xuanming Hong
KMKe Miao
Ke Miao
WCWeihua Cao
Weihua Cao
JLJun Lv
Jun Lv
CYCanqing Yu
Canqing Yu
LLLiming Li
Liming Li
Background: Previous EWASs (Epigenome-Wide Association Studies) have reported hundreds of blood pressure (BP) associated 5′-cytosine-phosphate-guanine-3′ (CpG) sites. However, their results were inconsistent. Longitudinal observations on the temporal relationship between DNA methylation and BP are lacking. Methods: A candidate CpG site association study for BP was conducted on 1072 twins in the Chinese National Twin Registry. PubMed and EMBASE were searched for candidate CpG sites. Cross-lagged models were used to assess the temporal relationship between BP and DNA methylation in 308 twins who completed 2 surveys in 2013 and 2018. Then, the significant cross-lagged associations were validated by adopting the Inference About Causation From Examination of Familial Confounding approach. Finally, to evaluate the cumulative effects of DNA methylation on the progression of hypertension, we established methylation risk scores based on BP-associated CpG sites and performed Markov multistate models. Results: 16 and 20 CpG sites were validated to be associated with systolic BP and diastolic BP, respectively. In the cross-lagged analysis, we detected that methylation of 2 CpG sites could predict subsequent systolic BP, and systolic BP predicted methylation at another 3 CpG sites. For diastolic BP, methylation at 3 CpG sites had significant cross-lagged effects for predicting diastolic BP levels, while the prediction from the opposite direction was observed at one site. Among these, 3 associations were validated in the Inference About Causation From Examination of Familial Confounding analysis. Using the Markov multistate model, we observed that methylation risk scores were associated with the development of hypertension. Conclusions: Our findings suggest the significance of DNA methylation in the development of hypertension.

28 September 2022 in Diabetes
Verified
Journal Article
Closed access
PDF file
XHXuanming Hong
Xuanming Hong
ZWZhiyu Wu
Zhiyu Wu
WCWeihua Cao
Weihua Cao
JLJun Lv
Jun Lv
CYCanqing Yu
Canqing Yu
LLLiming Li
Liming Li
Investigators of previous cross-sectional epigenome-wide association studies (EWAS) in adults have reported hundreds of 5′-cytosine-phosphate-guanine-3′ (CpG) sites associated with type 2 diabetes mellitus (T2DM) and glycemic traits. However, the results from EWAS have been inconsistent, and longitudinal observations of these associations are scarce. Furthermore, few studies have investigated whether DNA methylation (DNAm) could be modified by smoking, drinking, and glycemic traits, which have broad impacts on genome-wide DNAm and result in altering the risk of T2DM. Twin studies provide a valuable tool for epigenetic studies, as twins are naturally matched for genetic information. In this study, we conducted a systematic literature search in PubMed and Embase for EWAS, and 214, 33, and 117 candidate CpG sites were selected for T2DM, HbA1c, and fasting blood glucose (FBG). Based on 1,070 twins from the Chinese National Twin Registry, 67, 17, and 16 CpG sites from previous studies were validated for T2DM, HbA1c, and FBG. Longitudinal review and blood sampling for phenotypic information and DNAm were conducted twice in 2013 and 2018 for 308 twins. A cross-lagged analysis was performed to examine the temporal relationship between DNAm and T2DM or glycemic traits in the longitudinal data. A total of 11 significant paths from T2DM to subsequent DNAm and 15 paths from DNAm to subsequent T2DM were detected, suggesting both directions of associations. For glycemic traits, we detected 17 cross-lagged associations from baseline glycemic traits to subsequent DNAm, and none were from the other cross-lagged direction, indicating that CpG sites may be the consequences, not the causes, of glycemic traits. Finally, a longitudinal mediation analysis was performed to explore the mediation effects of DNAm on the associations of smoking, drinking, and glycemic traits with T2DM. No significant mediations of DNAm in the associations linking smoking and drinking with T2DM were found. In contrast, our study suggested a potential role of DNAm of cg19693031, cg00574958, and cg04816311 in mediating the effect of altered glycemic traits on T2DM.

14 November 2024 in Aging Cell
Verified
Journal Article
Open access
XHXuanming Hong
Xuanming Hong
HCHui Cao
Hui Cao
WCWeihua Cao
Weihua Cao
JLJun Lv
Jun Lv
CYCanqing Yu
Canqing Yu
LLLiming Li
Liming Li
Several crucial acceleration periods exist during aging process. Epigenetic clocks, serving as indicators of aging, are influenced by genetic factors. Investigating how the genetic contributions on these clocks change with age may provide novel insights into the aging process. In this study, based on 1084 adult twins from the Chinese National Twin Registry (CNTR), we established structural equation models (SEMs) to evaluate the trends in genetic influence with aging for epigenetic clocks, which include PC‐Horvath, PC‐Hannum, PC‐PhenoAge, PC‐GrimAge, and DunedinPACE. A decline in overall heritability was observed for all five clocks from ages 31 to 70, with a relatively stable trend at first. Subsequently, apart from PC‐GrimAge, the other four clocks displayed a more evident drop in heritability: DunedinPACE and PC‐PhenoAge experienced a clear decline between 55 and 65 years, while PC‐Horvath and PC‐Hannum showed a similar decrease between 60 and 70 years. In contrast, the heritability of PC‐GrimAge remained stable throughout. An analysis of methylation sites (CpGs) from these clocks identified 41, 26, 4, and 36 CpG sites potentially underlying heritability changes in DunedinPACE, PC‐Horvath, PC‐Hannum, and PC‐PhenoAge, respectively. Data from the CNTR were collected through two surveys in 2013 and 2018. Based on 308 twins with longitudinal data, declines in genetic components were observed at follow‐up compared to baseline, with significant decreases in the four PC‐clocks. DunedinPACE peaked in 5‐year longitudinal genetic contribution changes at age 55–60, while PC‐clocks consistently peaked at age 50–55. These findings may offer novel insights into the role of genetic variations in aging.

31 October 2023 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
XHXuanming Hong
Xuanming Hong
KMKe Miao
Ke Miao
WCWeihua Cao
Weihua Cao
JLJun Lv
Jun Lv
CYCanqing Yu
Canqing Yu
LLLiming Li
Liming Li